We performed a 2-year RCT with RA patients at the Center for Rheumatology and Spine Diseases, Copenhagen University Hospital Gentofte, capital region of Copenhagen, Denmark. At baseline, patients were randomly assigned (1:1) to the OOCP or TSRF group using a web-based secure centralised system with stratification according to biologic and non-biologic treatment [9]. Patients were evaluated at baseline and years 1 and 2, including assessment of disease activity and reporting of outcome measures on a touch screen at the clinic [10]. One blinded, senior project rheumatologist, who did not take part in the treatment or daily clinic, examined all the patients at baseline and years 1 and 2. The patient’s usual rheumatologist performed the other visits, and in total, 13 rheumatologists in the clinic took part in the study.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.